JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
Clinical trial NCT06944470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06944470
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2027-04-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.